Single-Cell Omics Market Share, Trends & Forecast by 2034

Single-Cell Omics Market Overview for 2024 to 2034

The single-cell omics market is anticipated to be worth US$ 3.6 billion in 2024. The market is expected to grow at a CAGR of 19.5% from 2024 to 2034. By the end of the forecast period, the market is predicted to hit US$ 21.3 billion.

Single Cell Omics Market Size and Analysis

Rising demand for research and development activities toward cancer therapy is expected to drive the demand for single-cell omics.
Increasing cancer concerns worldwide are boosting market growth as single-cell omics act as an essential tool to decrease the complexity of tumors.
Increasing activities regarding drug discoveries and personalized medicines, drive the market forward.
Growing interest in biotechnology research is anticipated to fuel market demand in the coming years.
As omics technology allows analysis of different types of applications such as brain science, tumor immunology, and pre-implantation which gaining popularity across the globe.
Rising demand analysis of the difference between gene expressions in individual cells for the understanding of the intra-tumoral heterogeneity.
Growing government funding for research and development for the life sciences.
The need for precision medicine for targeted therapies is expected to drive the global demand for single-cell omics.

Attributes	Details
Single Cell Omics Market Size, 2024	US$ 3.6 billion
Projected Market Size, 2034	US$ 21.3 billion
Value-based CAGR (2024 to 2034)	19.5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Opportunity Analysis in the Single-Cell Omics Market

Rising chronic diseases and their need for therapies are expected to create lucrative opportunities for the forecast period.
Increasing research for the genomic compositions.
Single-cell genomics allows scientists and researchers to research the genomic composition of the individual cell.
Growing usage of omics-based instruments for cancer therapy advancements is anticipated to create significant opportunities in the single-cell omics market.
Investigation into transcriptomics and proteomics are gaining popularity among world scientists in the current period.
Surge in innovation and research studies conducted by academic and research institutions presents greater opportunities in the single-cell omics market.

Restraints in the Single-Cell Omics Market

Increasing complexity of data which is generated by the single-cell omics approach is expected to hamper the market growth during the forecast period.
Availability of limited technology and limited sensitivity which shows false results is a major challenge for the industry.
Lack of skilled professionals is anticipated to hinder the market expansion during the anticipated period. As need for well-educated and professional scientists has increased.
The lack of standardization in integration and data analysis is a major concern for the market growth.
The limited availability of funding for research and development across several regions.
The challenges associated with the rare cell population investigation act as a major restraining factor in the industry.
The stringent regulation of research and development by several governments is expected to hamper the market expansion in the projection period.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights

In Material Type, the Single-Cell Genomics Segment Leads the Market

Attributes	Details
Top Product Type	Single-Cell Genomics
CAGR from 2024 to 2034	19.3%

Increasing concerns regarding chronic diseases such as cancer and others are driving demand for the single-cell genomics segment
Rising need for an alternative therapy option over traditional methods.
Growing need for a cost-effective procedure for the single-cell analysis is anticipated to propel the single-cell genomics segment growth.
Factors such as high resolution, and the need for the identification of rare cell populations make single-cell genomics a popular option among consumers.
Surge in demand for precision medicine is leading to the increasing demand for single-cell genomics.
The recent innovations in genomics technology such as droplet-based sequencing and microfluidics are expected to drive demand for single-cell genomics

The Oncology Segment Dominates the Market by Application

Attributes	Details
Top Application	Oncology
CAGR from 2024 to 2034	19.1%

Increasing need for precise therapy and advanced diagnosis for chronic diseases.
Oncology provides better and precise therapies and greater diagnostics which make it a popular choice among the patients.
Advancements in technology as technology made it possible such as analyzing cell single with a greater accuracy and speed.
Thus, technological advancement is expected to drive the demand for the oncology segment.
Rising investment in public and private organizations for research purposes is anticipated to propel the segment in the forecast period.

Country-wise Insights

Countries	CAGR (2024 to 2034)
United States	19.8%
United Kingdom	20.7%
China	20.4%
Japan	21.3%
South Korea	22.0%

Rising Research and Development Activities in the United States

The market for single-cell omics in the United States is witnessing steady growth over the years driven by several factors.
The incidences related to cancer, cardiovascular diseases, and diabetes in the United States.
For instance, according to the American Cancer Society, an estimated 1.9 million new cancer cases in the United States will be diagnosed in 2021, and 608,570 cancer deaths.
Rising research and development activities in the United States are expected to drive the demand for single-cell omics.
Technological advancement in the United States played a crucial role in the single-cell omics market.
Increasing demand for personalized medicines in the United States. As single-cell omics allow researchers to identify specific genetic mutations which helps to develop personalized medicines.

Increasing Government Funding Toward Research and Development in the United Kingdom

Rising focus on the drug discovery and drug development in the United Kingdom.
Single-cell omics can identify new drug targets that are driving demand for the drug discovery process as single-cell analysis tools are used in the pharmaceutical and biotech industries in the United Kingdom.
Increasing government funding toward research and development in the United Kingdom is driving the growth of the single-cell omics market in the United Kingdom.
The demand for precision medicines in the United Kingdom is rapidly increasing in several years.
Rising use of single-omics technology in agriculture and food research in the United Kingdom is expected to create lucrative opportunities in the single-cell omics market in the United Kingdom.

Increased Need for Effective and Precise Treatment in China

The single-cell omics industry in China has shown steady growth over the years owing to several factors.
The large and aging population is driving the demand for the single-cell omics market in China.
As a population consumes more utilities such as medicines and others in China.
Increased need for effective and precise treatment for patients in China. As having better healthcare infrastructure and facilities in China.
Single-cell omics allow for the identification of genetic mutation and biomarkers which enables the development of precise and effective treatment options.

Rising Demand for Targeted Healthcare and Personalized Healthcare Solutions in Japan.

Increasing number of the aging population in Japan.
Growing prevalence of diseases such as diabetes, cancer, and other chronic diseases is anticipated to drive the demand for the single-cell omics market.
As having advanced research centers and technologies, Japan is focusing on new drug development and drug discovery.
The drug discovery leads the single-cell omics industry growth in Japan.
Rising need for targeted healthcare and personalized healthcare solutions in Japan.
Increasing single-cell sequencing in Japan for research. Sequencing is useful to study a wide range of biological processes and others.

Growing Use of Single-Cell Analysis Tools in South Korea.

The market for single-cell omics in South Korea has been experiencing lucrative opportunities in recent years.
The rising drug discoveries and drug development in South Korea have gained major market share in the country for the single-cell omics market.
Growing use of single-cell analysis tools in South Korea.
As scientists and researchers are using this tool for several research purposes which is driving demand for the single-cell omics market in South Korea.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Competitive Landscape

The market is highly competitive, with several key players vying for higher profit share. These companies offer a range of single-cell analysis tools and technologies, including single-cell sequencing platforms, microfluidic devices, and software for data analysis and interpretation.

As the demand for single cell analysis tools and technologies continues to grow, the market is expected to become even more competitive, with new players entering the market and established players expanding their offerings.

Recent Developments

In 2023, Singular Genomics Systems, Inc. recently launched its Max read kits for single cell applications on the company's G4 sequencing platform. Singular Genomics Systems, Inc. is a California-based life sciences company that specializes in developing innovative sequencing technologies for genomic and transcriptomic analysis. Its recent launch of the Max read kits for single-cell applications on the company's G4 sequencing platform is expected to address the growing need for high-throughput single cell sequencing. The Max read kits offer a unique combination of high read accuracy and long read lengths, enabling researchers to analyze individual cells in greater detail than ever before.
In 2023, Illumina Inc., a leading provider of DNA sequencing and array-based technologies, has recently announced the opening of a new office and Illumina Solutions Center in Bengaluru, India. The new facility is equipped with state-of-the-art technology and is expected to support the company's growing customer base in India and the broader Asia-Pacific region. The Illumina Solutions Center in Bengaluru will offer access to Illumina's portfolio of genomics solutions, including next-generation sequencing platforms, arrays, and software for data analysis and interpretation.

Key Market Players

Mission Bio
RareCyte, Inc.
Cytena
WaferGen Bio-systems
Dolomite Bio
Menarini Silicon Biosystems
NanoCellect Biomedical
Sphere Fluidics
1CellBio
OnRamp Bioinformatics
10x Genomics
Illumina
Thermo Fisher Scientific
Fluidigm Corporation
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Takara Bio, Inc.
QIAGEN
Norgen Biotek Corp.
Fluxion Biosciences, Inc.

Key Coverage in the Single-Cell Omics Market Report

Single-Cell Transcriptomics Market Report
Single-Cell Genomics Market Analysis
Single Cell Multiomics Market Statistics Assessment
Single-Cell Metabolomics Market overview
Single Cell Multiomics Kits Pricing Outlook

Key Market Segmentation

By Product Type:

Single-cell Genomics
Single-cell Transcriptomics
Single-cell Proteomics
Single-cell Metabolomics

By Application:

Oncology
Cell Biology
Neurology
Immunology
Other Applications

By End User:

Academic and Research Organizations
Pharmaceutical & Biotechnology Companies
Hospital and Diagnostic Laboratories
Other End-Users

By Region:

North America
Latin America
East Asia
South Asia
Europe
Oceania
MEA

Frequently Asked Questions

How Big is the Single Cell Omics Market in 2024?

The single cell omics market is estimated to be valued at US$ 3.6 billion in 2024.

What is China’s Market Outlook?

The market in China is expected to progress at a CAGR of 20.4% through the forecast period.

Which Product Type Segment Contributes More to the Single Cell Omics Market?

The single cell genomics segment is expected to register a CAGR of 19.3% through 2034.

What is the United States Market Outlook?

The United States market is expected to register a CAGR of 19.8% from 2024 to 2034.

What is the Projected Market Value by 2034?

The market is set to reach a valuation of around US$ 21.3 billion by the end of 2034.

What Was the Historical CAGR for the Market?

The demand for single-cell omics increased at a 23.9% CAGR from 2019 to 2023.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2019 to 2023

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2024 to 2034

5.3.1. Single-Cell Genomics

5.3.2. Single-Cell Transcriptomics

5.3.3. Single-Cell Proteomics

5.3.4. Single-Cell Metabolomics

5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034

6.3.1. Oncology

6.3.2. Cell Biology

6.3.3. Neurology

6.3.4. Immunology

6.3.5. Other Applications

6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) Analysis By End-user, 2019 to 2023

7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-user, 2024 to 2034

7.3.1. Academic and Research Organizations

7.3.2. Pharmaceutical & Biotechnology Companies

7.3.3. Hospital and Diagnostic Laboratories

7.3.4. Other End-Users

7.4. Y-o-Y Growth Trend Analysis By End-user, 2019 to 2023

7.5. Absolute $ Opportunity Analysis By End-user, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. South Asia and Pacific

8.3.6. East Asia

8.3.7. Middle East and Africa

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

9.2.1. By Country

9.2.1.1. USA

9.2.1.2. Canada

9.2.2. By Product Type

9.2.3. By Application

9.2.4. By End-user

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product Type

9.3.3. By Application

9.3.4. By End-user

9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Product Type

10.2.3. By Application

10.2.4. By End-user

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product Type

10.3.3. By Application

10.3.4. By End-user

10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. UK

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Western Europe

11.2.2. By Product Type

11.2.3. By Application

11.2.4. By End-user

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product Type

11.3.3. By Application

11.3.4. By End-user

11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. Poland

12.2.1.2. Russia

12.2.1.3. Czech Republic

12.2.1.4. Romania

12.2.1.5. Rest of Eastern Europe

12.2.2. By Product Type

12.2.3. By Application

12.2.4. By End-user

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product Type

12.3.3. By Application

12.3.4. By End-user

12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. India

13.2.1.2. Bangladesh

13.2.1.3. Australia

13.2.1.4. New Zealand

13.2.1.5. Rest of South Asia and Pacific

13.2.2. By Product Type

13.2.3. By Application

13.2.4. By End-user

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product Type

13.3.3. By Application

13.3.4. By End-user

13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. China

14.2.1.2. Japan

14.2.1.3. South Korea

14.2.2. By Product Type

14.2.3. By Application

14.2.4. By End-user

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product Type

14.3.3. By Application

14.3.4. By End-user

14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Israel

15.2.1.4. Rest of MEA

15.2.2. By Product Type

15.2.3. By Application

15.2.4. By End-user

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Product Type

15.3.3. By Application

15.3.4. By End-user

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. USA

16.1.1. Market Share Analysis, 2023

16.1.1.1. By Product Type

16.1.1.2. By Application

16.1.1.3. By End-user

16.2. Canada

16.2.1. Market Share Analysis, 2023

16.2.1.1. By Product Type

16.2.1.2. By Application

16.2.1.3. By End-user

16.3. Brazil

16.3.1. Market Share Analysis, 2023

16.3.1.1. By Product Type

16.3.1.2. By Application

16.3.1.3. By End-user

16.4. Mexico

16.4.1. Market Share Analysis, 2023

16.4.1.1. By Product Type

16.4.1.2. By Application

16.4.1.3. By End-user

16.5. Germany

16.5.1. Market Share Analysis, 2023

16.5.1.1. By Product Type

16.5.1.2. By Application

16.5.1.3. By End-user

16.6. UK

16.6.1. Market Share Analysis, 2023

16.6.1.1. By Product Type

16.6.1.2. By Application

16.6.1.3. By End-user

16.7. France

16.7.1. Market Share Analysis, 2023

16.7.1.1. By Product Type

16.7.1.2. By Application

16.7.1.3. By End-user

16.8. Spain

16.8.1. Market Share Analysis, 2023

16.8.1.1. By Product Type

16.8.1.2. By Application

16.8.1.3. By End-user

16.9. Italy

16.9.1. Market Share Analysis, 2023

16.9.1.1. By Product Type

16.9.1.2. By Application

16.9.1.3. By End-user

16.10. Poland

16.10.1. Market Share Analysis, 2023

16.10.1.1. By Product Type

16.10.1.2. By Application

16.10.1.3. By End-user

16.11. Russia

16.11.1. Market Share Analysis, 2023

16.11.1.1. By Product Type

16.11.1.2. By Application

16.11.1.3. By End-user

16.12. Czech Republic

16.12.1. Market Share Analysis, 2023

16.12.1.1. By Product Type

16.12.1.2. By Application

16.12.1.3. By End-user

16.13. Romania

16.13.1. Market Share Analysis, 2023

16.13.1.1. By Product Type

16.13.1.2. By Application

16.13.1.3. By End-user

16.14. India

16.14.1. Market Share Analysis, 2023

16.14.1.1. By Product Type

16.14.1.2. By Application

16.14.1.3. By End-user

16.15. Bangladesh

16.15.1. Market Share Analysis, 2023

16.15.1.1. By Product Type

16.15.1.2. By Application

16.15.1.3. By End-user

16.16. Australia

16.16.1. Market Share Analysis, 2023

16.16.1.1. By Product Type

16.16.1.2. By Application

16.16.1.3. By End-user

16.17. New Zealand

16.17.1. Market Share Analysis, 2023

16.17.1.1. By Product Type

16.17.1.2. By Application

16.17.1.3. By End-user

16.18. China

16.18.1. Market Share Analysis, 2023

16.18.1.1. By Product Type

16.18.1.2. By Application

16.18.1.3. By End-user

16.19. Japan

16.19.1. Market Share Analysis, 2023

16.19.1.1. By Product Type

16.19.1.2. By Application

16.19.1.3. By End-user

16.20. South Korea

16.20.1. Market Share Analysis, 2023

16.20.1.1. By Product Type

16.20.1.2. By Application

16.20.1.3. By End-user

16.21. GCC Countries

16.21.1. Market Share Analysis, 2023

16.21.1.1. By Product Type

16.21.1.2. By Application

16.21.1.3. By End-user

16.22. South Africa

16.22.1. Market Share Analysis, 2023

16.22.1.1. By Product Type

16.22.1.2. By Application

16.22.1.3. By End-user

16.23. Israel

16.23.1. Market Share Analysis, 2023

16.23.1.1. By Product Type

16.23.1.2. By Application

16.23.1.3. By End-user

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Product Type

17.3.3. By Application

17.3.4. By End-user

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. CELLENION

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.2. PerkinElmer Inc.

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.3. 10x Genomics

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.4. ANGLE plc

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.5. Illumina, Inc.

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.6. Bio-Rad Laboratories, Inc

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

18.1.7. MissionBio

18.1.7.1. Overview

18.1.7.2. Product Portfolio

18.1.7.3. Profitability by Market Segments

18.1.7.4. Sales Footprint

18.1.7.5. Strategy Overview

18.1.7.5.1. Marketing Strategy

18.1.8. Fluidigm Corporation

18.1.8.1. Overview

18.1.8.2. Product Portfolio

18.1.8.3. Profitability by Market Segments

18.1.8.4. Sales Footprint

18.1.8.5. Strategy Overview

18.1.8.5.1. Marketing Strategy

18.1.9. 1CellBio

18.1.9.1. Overview

18.1.9.2. Product Portfolio

18.1.9.3. Profitability by Market Segments

18.1.9.4. Sales Footprint

18.1.9.5. Strategy Overview

18.1.9.5.1. Marketing Strategy

18.1.10. Takara Bio

18.1.10.1. Overview

18.1.10.2. Product Portfolio

18.1.10.3. Profitability by Market Segments

18.1.10.4. Sales Footprint

18.1.10.5. Strategy Overview

18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Single-Cell Omics Market

Single-Cell Omics Market Forecast by Single-cell Genomics and Single-cell Transcriptomics from 2024 to 2034